文献速递胰腺与胆道疾病消化内镜

内镜下胆囊支架置入预防延迟胆囊切除术患者复发性胆囊炎:一项随机试验

Endoscopic Gallbladder Stenting to Prevent Recurrent Cholecystitis in Deferred Cholecystectomy: A Randomized Trial.
PubMed 文献 · Gastroenterology · 2024-02-14

本研究纳入120例急性结石性胆囊炎且疑似胆总管结石、因COVID-19手术封锁无法早期行胆囊切除术的患者,随机分为接受内镜下经乳头胆囊支架置入(ETGS)组和不接受ETGS组。

要点

  • ETGS可显著降低延迟胆囊切除术患者3个月内复发性胆囊炎风险。
  • 未接受ETGS者复发多发生在3个月内,3-6个月复发风险较低。
  • ETGS技术成功率90%,临床成功率100%。

核心结论

  • 对于因手术推迟而无法早期行胆囊切除术的急性结石性胆囊炎患者,ETGS可预防3个月内复发性胆囊炎。

研究设计与样本

  • 2020-2023年随机对照试验,纳入120例急性结石性胆囊炎、疑似胆总管结石且因COVID-19手术封锁无法早期手术的患者,随机分为ETGS组(n=60)和对照组(n=60),计划3个月或更后行 definitive 胆囊切除术。

主要发现

  • ETGS组技术成功率为90%(54/60),临床成功率为100%(54/54)。

临床怎么用

  • 对于因手术延迟无法早期行胆囊切除术的急性结石性胆囊炎患者,可考虑ETGS以降低3个月内复发性胆囊炎风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Endoscopic transpapillary gallbladder stenting (ETGS) has been proposed as one of the adjunctive treatments, apart from antibiotics, before surgery in patients with acute cholecystitis whose cholecystectomy could not be performed or was deferred. Currently, there are no comparative data on the outcomes of ETGS in those who receive and do not receive ETGS. We aimed to compare the rates of recurrent cholecystitis at 3 and 6 months in these 2 groups. METHODS: Between 2020 and 2023, eligible acute calculous cholecystitis patients with a high probability of common bile duct stone, who were surgical candidates but could not have an early cholecystectomy during COVID-19 surgical lockdown, were randomized into groups A (received ETGS) and B (did not receive ETGS). A definitive cholecystectomy was performed at 3 months or later in both groups. RESULTS: A total of 120 eligible patients were randomized into group A (n = 60) and group B (n = 60). In group A, technical and clinical success rates were 90% (54 of 60) and 100% (54 of 54), respectively. Based on intention-to-treat analysis, group A had a significantly lower rate of recurrence than group B at 3 months (0% [0 of 60] vs 18.3% [11 of 60]; P = .001). At 3-6 months, group A showed a nonsignificantly lower rate of recurrent cholecystitis compared to group B (0% [0 of 32] vs 10% [3 of 30]; P = .11). CONCLUSIONS: ETGS could prevent recurrent cholecystitis in acute cholecystitis patients with common bile duct stone whose cholecystectomy was deferred for 3 months. In those who did not receive ETGS, the majority of recurrences occurred within 3 months. (Thaiclinicaltrials.org, Number TCTR20200913001).

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Ridtitid W, Karuehardsuwan J, Faknak N, et al. Endoscopic Gallbladder Stenting to Prevent Recurrent Cholecystitis in Deferred Cholecystectomy: A Randomized Trial. Gastroenterology. 2024. PMID: 38360274. doi:10.1053/j.gastro.2024.02.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。